Intelligence Platform

Patents

Browse 1,166 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 10301377

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10300115

Methods and compositions for modulating immune tolerance

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10301314

Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10293005

Use of gram negative species to treat atopic dermatitis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10287279

Inhibitors of human 12/15-lipoxygenase

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10287297

Epoxyazulene derivatives useful for treating cancer and diabetes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10286050

Multi-epitope TARP peptide vaccine and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10287340

Anti-HIV domain antibodies and method of making and using same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10287350

Chimeric antigen receptors targeting CD-19

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10281475

Systems and methods to identify and treat subjects at risk for obstetrical complications

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10280307

Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10272039

Topical sodium nitrite formulation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10273288

Neutralizing antibodies to Ebola virus glycoprotein and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10273291

Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10273299

Antibodies to tumor endothelial marker 8

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10266565

Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10265382

Complexes of IL-15 and IL-15Ralpha and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10265313

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10258682

Attenuated chlamydia vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10258701

Labeled evans blue dye derivative for in vivo serum albumin labeling

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10251912

MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10246463

Hypoxia-inducible factor 1 (HIF-1) inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10246505

Chimeric antigen receptors to control HIV infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10233209

Inhibitors of the farnesoid x receptor and uses in medicine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)